Literature DB >> 2765393

Renal structure and function in streptozotocin-diabetic rats treated with cyclosporin A.

K J Thomson1, N J Saunders, J G Simpson, P H Whiting.   

Abstract

The effect of cyclosporin A (CsA), administered daily by gavage at 20 mg/kg body weight, on renal structure and function was investigated in normal and streptozotocin-diabetic male adult Sprague-Dawley rats over 12 weeks. In the non-diabetic animals CsA caused a progressive decrease in glomerular filtration rate and increased enzymuria. In contrast, the diabetic state was associated with massive increases in both enzymuria and urine flow rates, but a trend towards increased urea and creatinine clearance rates. CsA treatment of diabetic animals did not significantly alter the above parameters, nor affect circulating glucose levels, and trough serum CsA concentrations were similar in both diabetic and non-diabetic animals. The kidneys from CsA-treated non-diabetic animals showed chronic tubular damage. In the streptozotocin groups, the only morphological abnormality which could be related to diabetes was excess glycogen deposition in distal renal tubules. CsA-treatment of these groups was not associated with structural enhancement of either the drug's nephrotoxicity or the diabetes-related changes. Indeed the results indicate that the diabetic state affords some protection against the functional aspects of CsA-nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765393      PMCID: PMC2040564     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  11 in total

1.  The pathology of Armanni-Ebstein diabetic nephropathy.

Authors:  S RITCHIE; D WAUGH
Journal:  Am J Pathol       Date:  1957 Nov-Dec       Impact factor: 4.307

2.  The renal excretion of inositol by normal and diabetic rats.

Authors:  W H DAUGHADAY; J LARNER; E HOUGHTON
Journal:  J Clin Invest       Date:  1954-08       Impact factor: 14.808

3.  Chronic renal damage caused by cyclosporine.

Authors:  J G Simpson; N J Saunders; K J Thomson; P H Whiting
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

4.  Energy- and sodium-dependent uptake of inositol by kidney cortex slices.

Authors:  G Hauser
Journal:  Biochem Biophys Res Commun       Date:  1965-06-09       Impact factor: 3.575

5.  Cyclosporine. Liver and pancreas transplantation.

Authors: 
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

6.  Abnormal sciatic nerve myo-inositol metabolism in the streptozotocin-diabetic rat: effect of insulin treatment.

Authors:  R S Clements; C R Stockard
Journal:  Diabetes       Date:  1980-03       Impact factor: 9.461

7.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

8.  Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes.

Authors:  P H Whiting; K P Palmano; J N Hawthorne
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

9.  Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes.

Authors:  K P Palmano; P H Whiting; J N Hawthorne
Journal:  Biochem J       Date:  1977-10-01       Impact factor: 3.857

Review 10.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.